Guliaev V P, Masenko V P, Iurenev A P, Titov V N
Kardiologiia. 1992 Mar;32(3):11-3.
The results from recent studies suggest that the endogenous opioid beta-endorphin (beta-E) is related to pain modulation. Therefore, plasma beta-E levels were studied in 23 patients with essential hypertension (EH) and in 7 patients with coronary artery disease (CAD) during asymptomatic ischemic events and in 5 patients with CAD during symptomatic ischemic events. Blood samples for beta-E were taken at the moment of silent ST depression, pointed with alarm by the real time ECG monitor "Q Med Monitor" (USA). Control blood samples were taken under the same conditions without ischemic events. Control plasma beta-E levels were significantly higher (p less than 0.01) in patients with EH as compared to that in both groups of patients with CAD (22.9 +/- 4.0 vs 7.0 +/- 1.9 and 4.5 +/- 1.6 pmol/l). At the time of silent ischemia, beta-E showed a significant increase in patients with EH (+10.1 +/- 2.1 pmol/l, p less than 0.01) and in patients with CAD (+10.7 +/- 1.3 pmol/l, p less than 0.05) as compared to the control levels. However, plasma beta-E showed no increase (+1.0 +/- 0.6 pmol/l, p greater than 0.1) during symptomatic ischemia as compared to the control levels. Thus, differences in the circulating levels of beta-E may be associated with the presence or absence of pain during myocardial ischemia.
近期研究结果表明,内源性阿片样物质β-内啡肽(β-E)与疼痛调节有关。因此,我们对23例原发性高血压(EH)患者、7例冠心病(CAD)患者无症状性缺血事件期间以及5例冠心病患者有症状性缺血事件期间的血浆β-E水平进行了研究。β-E的血样在实时心电图监测仪“Q Med Monitor”(美国)发出警报提示的静息ST段压低时刻采集。对照血样在无缺血事件的相同条件下采集。与两组冠心病患者相比,EH患者的对照血浆β-E水平显著更高(p<0.01)(分别为22.9±4.0 vs 7.0±1.9和4.5±1.6 pmol/L)。在静息缺血时,与对照水平相比,EH患者(+10.1±2.1 pmol/L,p<0.01)和CAD患者(+10.7±1.3 pmol/L,p<0.05)的β-E显著升高。然而,与对照水平相比,有症状性缺血期间血浆β-E未升高(+1.0±0.6 pmol/L,p>0.1)。因此,β-E循环水平的差异可能与心肌缺血期间疼痛的有无有关。